Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul A Mieyal
AddedMar 31, 2024
UpdatedMay 1, 2026
Paul A Mieyal

Paul A Mieyal

Board Member, Interventional Spine

Paul A Mieyal's Career

Interventional Spine
Interventional Spine

Irvine, CA, US

Board Member· Board
Optiscan Biomedical
Optiscan Biomedical

Hayward, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul A Mieyal's Career

Interventional Spine
Interventional Spine
Series A$51.4M442000Irvine, CA, US
Board Member· Board

Leadership at Interventional Spine

Stephen L WilsonStephen L WilsonBoard Member
Walter A. CuevasWalter A. CuevasBoard Member
Victor V. CachiaVictor V. CachiaFounder
Ashton HudsonAshton HudsonBoard Member
Dr Thomas ThalerDr Thomas ThalerBoard Member
Franklin D BrownFranklin D BrownBoard Member

Similar to Interventional Spine

Integral Spine SolutionsIntegral Spine SolutionsCarlsbad, CA, USMedical Devicesest. 2010Integral Spine SolutionsCarlsbad, CA, US · est. 2010

Integral Spine Solutions, based in California, innovates proprietary procedures and products for interbody fusion surgery.

Angel · $318.9k6
FlexuspineFlexuspinePittsburgh, PA, USMedical Devicesest. 2003FlexuspinePittsburgh, PA, US · est. 2003

Flexuspine Inc.: Innovating spinal treatment with advanced medical device manufacturing.

Pre-Seed · $3.2M7
SpineologySpineologySt. Paul Park, MN, USMedical Devicesest. 1997SpineologySt. Paul Park, MN, US · est. 1997

Spineology, Inc.: A US-based producer and distributor of advanced medical instruments for spinal care.

Series A · $28.6M103
Spinal RestorationSpinal RestorationAustin, TX, USMedical Devicesest. 2004Spinal RestorationAustin, TX, US · est. 2004

Spinal Restoration, Inc.: Global provider of minimally invasive, early intervention medical devices for chronic disc pain.

Public · $46M5
Optiscan Biomedical
Optiscan Biomedical
Series E$165M751994Hayward, CA, US
Board Member· Board

Leadership at Optiscan Biomedical

NOAH J KROLOFFNOAH J KROLOFFBoard Member
Cary VanceCary VanceBoard Member
Tara ButlerTara ButlerBoard Member
Kenneth AbramowitzKenneth AbramowitzBoard Member
Scott HalstedScott HalstedBoard Member
Daniel GoldbergerDaniel GoldbergerFounder

Similar to Optiscan Biomedical

GlumetricsGlumetricsIrvine, CA, USGlucose Monitors, Medical Devicesest. 2005GlumetricsIrvine, CA, US · est. 2005

GluMetrics Inc.: A US-based medical device company specializing in innovative glucose monitoring solutions.

Series A · $68.2M30
GlysensGlysensSan Diego, CA, USGlucose Monitorsest. 1998GlysensSan Diego, CA, US · est. 1998

San Diego-based GlySens, Inc. manufactures implantable glucose monitors for enhanced diabetes care across the US.

Series D · $34M75
DexcomDexcomSan Diego, CA, USGlucose Monitors, Medical Devicesest. 1999DexcomSan Diego, CA, US · est. 1999

Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.

Public · $1.4B7.6k
GlucoVistaGlucoVistaFairfield Township, NJ, USMedical Devicesest. 2006GlucoVistaFairfield Township, NJ, US · est. 2006

GlucoVista Inc.: A US-based medical device company specializing in non-invasive blood glucose measuring equipment.

Seed · $2.7M3

Paul A Mieyal's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Paul A Mieyal

Robert BanksRobert BanksCEO · NephrosLee McCrackenLee McCrackenCEO · NephrosantHaydar AlirezaHaydar AlirezaBoard Member · Jcdecaux SA Jcdecaux S.A.Michael SenMichael SenBoard Member · Fresenius Medical CareMichael PanMichael PanCEO · Nephosity